BIOGEN INC. Selling, General and Administrative Expense
BIOGEN INC. (BIIB) reported Selling, General and Administrative Expense of $607.30 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-04-29
- BIOGEN INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $607.30M, a 6.08% increase year-over-year.
- BIOGEN INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $682.50M, a 0.37% increase year-over-year.
- BIOGEN INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $594.80M, a 1.09% increase year-over-year.
- BIOGEN INC. selling, general and administrative expense for the quarter ending 2025-06-30 was $583.80M, a 5.42% increase year-over-year.
- BIOGEN INC. selling, general and administrative expense for fiscal 2025 was $2.43B, a 1.24% increase from fiscal 2024.
- BIOGEN INC. selling, general and administrative expense for fiscal 2024 was $2.40B, a 5.73% decline from fiscal 2023.
- BIOGEN INC. selling, general and administrative expense for fiscal 2023 was $2.55B, a 6.08% increase from fiscal 2022.
- BIOGEN INC. selling, general and administrative expense for fiscal 2022 was $2.40B, a 10.12% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $607.30M 10-Q · filed 2026-04-29 | $1.29B derived: sum of 2 quarters · filed 2026-04-29 | $1.88B derived: sum of 3 quarters · filed 2026-04-29 | $2.47B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $682.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $1.28B derived: sum of 2 quarters · filed 2026-02-06 | $1.86B derived: sum of 3 quarters · filed 2026-02-06 | $2.43B 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $594.80M 10-Q · filed 2025-10-30 | $1.18B derived: sum of 2 quarters · filed 2025-10-30 | $1.75B 10-Q · filed 2025-10-30 | $2.43B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $583.80M 10-Q · filed 2025-07-31 | $1.16B 10-Q · filed 2025-07-31 | $1.84B derived: sum of 3 quarters · filed 2026-04-29 | $2.42B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $572.50M 10-Q · filed 2026-04-29 | $1.25B derived: sum of 2 quarters · filed 2026-04-29 | $1.84B derived: sum of 3 quarters · filed 2026-04-29 | $2.39B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $680.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $1.27B derived: sum of 2 quarters · filed 2026-02-06 | $1.82B derived: sum of 3 quarters · filed 2026-02-06 | $2.40B 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $588.40M 10-Q · filed 2025-10-30 | $1.14B derived: sum of 2 quarters · filed 2025-10-30 | $1.72B 10-Q · filed 2025-10-30 | $2.33B derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $553.80M 10-Q · filed 2025-07-31 | $1.14B 10-Q · filed 2025-07-31 | $1.74B derived: sum of 3 quarters · filed 2026-02-06 | $2.53B derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $581.50M 10-Q · filed 2025-05-01 | $1.19B derived: sum of 2 quarters · filed 2026-02-06 | $1.98B derived: sum of 3 quarters · filed 2026-02-06 | $2.53B derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | $608.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $1.40B derived: sum of 2 quarters · filed 2026-02-06 | $1.94B derived: sum of 3 quarters · filed 2026-02-06 | $2.55B 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $788.20M 10-Q · filed 2024-10-30 | $1.34B derived: sum of 2 quarters · filed 2024-10-30 | $1.94B 10-Q · filed 2024-10-30 | $2.57B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $548.00M 10-Q · filed 2024-08-01 | $1.15B 10-Q · filed 2024-08-01 | $1.79B derived: sum of 3 quarters · filed 2025-02-12 | $2.35B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $605.00M 10-Q · filed 2024-04-24 | $1.24B derived: sum of 2 quarters · filed 2025-02-12 | $1.80B derived: sum of 3 quarters · filed 2025-02-12 | $2.37B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $632.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $1.20B derived: sum of 2 quarters · filed 2025-02-12 | $1.77B derived: sum of 3 quarters · filed 2025-02-12 | $2.40B 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $563.30M 10-Q · filed 2023-11-08 | $1.14B derived: sum of 2 quarters · filed 2023-11-08 | $1.77B 10-Q · filed 2023-11-08 | $2.56B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $572.60M 10-Q · filed 2023-07-25 | $1.21B 10-Q · filed 2023-07-25 | $2.00B derived: sum of 3 quarters · filed 2024-02-14 | $2.65B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $634.90M 10-Q · filed 2023-04-25 | $1.42B derived: sum of 2 quarters · filed 2024-02-14 | $2.08B derived: sum of 3 quarters · filed 2024-02-14 | $2.71B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $787.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $1.44B derived: sum of 2 quarters · filed 2024-02-14 | $2.08B derived: sum of 3 quarters · filed 2024-02-14 | $2.67B 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $654.10M 10-Q · filed 2022-10-25 | $1.29B derived: sum of 2 quarters · filed 2022-10-25 | $1.89B 10-Q · filed 2022-10-25 | $2.69B derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $637.30M 10-Q · filed 2022-07-20 | $1.23B 10-Q · filed 2022-07-20 | $2.04B derived: sum of 3 quarters · filed 2023-02-15 | $2.61B derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $595.00M 10-Q · filed 2022-05-03 | $1.40B derived: sum of 2 quarters · filed 2023-02-15 | $1.97B derived: sum of 3 quarters · filed 2023-02-15 | $2.53B derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $806.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $1.38B derived: sum of 2 quarters · filed 2023-02-15 | $1.93B derived: sum of 3 quarters · filed 2023-02-15 | $2.50B 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $573.10M 10-Q · filed 2021-10-20 | $1.13B derived: sum of 2 quarters · filed 2021-10-20 | $1.70B 10-Q · filed 2021-10-20 | $2.36B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $555.10M 10-Q · filed 2021-07-22 | $1.13B 10-Q · filed 2021-07-22 | $1.79B derived: sum of 3 quarters · filed 2022-02-03 | $2.34B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $570.10M 10-Q · filed 2021-04-22 | $1.24B derived: sum of 2 quarters · filed 2022-02-03 | $1.79B derived: sum of 3 quarters · filed 2022-02-03 | $2.38B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $664.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $1.22B derived: sum of 2 quarters · filed 2022-02-03 | $1.81B derived: sum of 3 quarters · filed 2022-02-03 | $2.37B 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $554.50M 10-Q · filed 2020-10-21 | $1.14B derived: sum of 2 quarters · filed 2020-10-21 | $1.71B 10-Q · filed 2020-10-21 | $2.30B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | $587.60M 10-Q · filed 2020-07-22 | $1.16B 10-Q · filed 2020-07-22 | $1.75B derived: sum of 3 quarters · filed 2021-02-03 | $2.24B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $567.70M 10-Q · filed 2020-04-23 | $1.16B derived: sum of 2 quarters · filed 2021-02-03 | $1.66B derived: sum of 3 quarters · filed 2021-02-03 | $2.17B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $591.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $1.09B derived: sum of 2 quarters · filed 2021-02-03 | $1.60B derived: sum of 3 quarters · filed 2021-02-03 | $2.11B 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $497.70M 10-Q · filed 2019-10-22 | $1.01B derived: sum of 2 quarters · filed 2019-10-22 | $1.52B 10-Q · filed 2019-10-22 | $2.09B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $516.20M 10-Q · filed 2019-07-24 | $1.02B 10-Q · filed 2019-07-24 | $1.59B derived: sum of 3 quarters · filed 2020-02-06 | $2.02B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $501.30M 10-Q · filed 2019-04-24 | $1.07B derived: sum of 2 quarters · filed 2020-02-06 | $1.51B derived: sum of 3 quarters · filed 2020-02-06 | $1.94B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $572.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $1.01B derived: sum of 2 quarters · filed 2020-02-06 | $1.44B derived: sum of 3 quarters · filed 2020-02-06 | $1.93B 10-K · filed 2020-02-06 | $1.94B 10-K · filed 2018-02-01 | |||
| 2017-09-30 | $433.40M 10-Q · filed 2018-10-23 | $433.80M 10-Q · filed 2017-10-24 | $863.20M derived: sum of 2 quarters · filed 2018-10-23 | $1.36B 10-Q · filed 2018-10-23 | $1.36B 10-Q · filed 2017-10-24 | $1.86B derived: sum of 4 quarters · filed 2019-02-06 | ||
| 2017-06-30 | $429.80M 10-Q · filed 2018-07-24 | $430.20M 10-Q · filed 2017-07-25 | $928.50M 10-Q · filed 2018-07-24 | $929.30M 10-Q · filed 2017-07-25 | $1.42B derived: sum of 3 quarters · filed 2019-02-06 | $1.89B derived: sum of 4 quarters · filed 2019-02-06 | ||
| 2017-03-31 | $498.70M 10-Q · filed 2018-04-24 | $499.10M 10-Q · filed 2017-04-25 | $992.90M derived: sum of 2 quarters · filed 2019-02-06 | $1.46B derived: sum of 3 quarters · filed 2019-02-06 | $1.95B derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2016-12-31 | $494.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $956.90M derived: sum of 2 quarters · filed 2019-02-06 | $1.45B derived: sum of 3 quarters · filed 2019-02-06 | $1.95B 10-K · filed 2019-02-06 | $1.95B 10-K · filed 2017-02-02 | |||
| 2016-09-30 | $462.70M 10-Q · filed 2017-10-24 | $955.10M derived: sum of 2 quarters · filed 2017-10-24 | $1.45B 10-Q · filed 2017-10-24 | $2.04B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $492.40M 10-Q · filed 2017-07-25 | $989.70M 10-Q · filed 2017-07-25 | $1.57B derived: sum of 3 quarters · filed 2018-02-01 | $2.05B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $497.30M 10-Q · filed 2017-04-25 | $1.08B derived: sum of 2 quarters · filed 2018-02-01 | $1.56B derived: sum of 3 quarters · filed 2018-02-01 | $2.05B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $583.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $1.06B derived: sum of 2 quarters · filed 2018-02-01 | $1.55B derived: sum of 3 quarters · filed 2018-02-01 | $2.11B 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $477.80M 10-Q · filed 2016-10-26 | $477.83M 10-Q · filed 2015-10-21 | $969.70M derived: sum of 2 quarters · filed 2016-10-26 | $1.53B 10-Q · filed 2016-10-26 | $1.53B 10-Q · filed 2015-10-21 | $2.10B derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | $491.90M 10-Q · filed 2016-07-21 | $491.89M 10-Q · filed 2015-07-24 | $1.05B 10-Q · filed 2016-07-21 | $1.05B 10-Q · filed 2015-07-24 | $1.63B derived: sum of 3 quarters · filed 2017-02-02 | $2.20B derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | $560.40M 10-Q · filed 2016-04-21 | $560.36M 10-Q · filed 2015-04-24 | $1.13B derived: sum of 2 quarters · filed 2017-02-02 | $1.70B derived: sum of 3 quarters · filed 2017-02-02 | $2.28B derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $573.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $1.14B derived: sum of 2 quarters · filed 2017-02-02 | $1.72B derived: sum of 3 quarters · filed 2017-02-02 | $2.23B 10-K · filed 2017-02-02 | $2.23B 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $570.44M 10-Q · filed 2015-10-21 | $1.15B derived: sum of 2 quarters · filed 2015-10-21 | $1.66B 10-Q · filed 2015-10-21 | $2.18B derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $576.62M 10-Q · filed 2015-07-24 | $1.09B 10-Q · filed 2015-07-24 | $1.61B derived: sum of 3 quarters · filed 2016-02-03 | $2.02B derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $511.67M 10-Q · filed 2015-04-24 | $1.03B derived: sum of 2 quarters · filed 2016-02-03 | $1.44B derived: sum of 3 quarters · filed 2016-02-03 | $1.87B derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | $522.91M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $928.49M derived: sum of 2 quarters · filed 2016-02-03 | $1.36B derived: sum of 3 quarters · filed 2016-02-03 | $1.71B 10-K · filed 2016-02-03 | $1.71B 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $405.58M 10-Q · filed 2014-10-22 | $836.60M derived: sum of 2 quarters · filed 2014-10-22 | $1.19B 10-Q · filed 2014-10-22 | $1.57B derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $431.01M 10-Q · filed 2014-07-23 | $783.61M 10-Q · filed 2014-07-23 | $1.16B derived: sum of 3 quarters · filed 2015-02-04 | $1.46B derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $352.60M 10-Q · filed 2014-04-23 | $728.58M derived: sum of 2 quarters · filed 2015-02-04 | $1.03B derived: sum of 3 quarters · filed 2015-02-04 | $1.33B derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $375.98M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $675.61M derived: sum of 2 quarters · filed 2015-02-04 | $977.38M derived: sum of 3 quarters · filed 2015-02-04 | $1.28B 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $299.63M 10-Q · filed 2013-10-28 | $601.40M derived: sum of 2 quarters · filed 2013-10-28 | $901.49M 10-Q · filed 2013-10-28 | $1.19B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $301.77M 10-Q · filed 2013-07-25 | $601.86M 10-Q · filed 2013-07-25 | $885.77M derived: sum of 3 quarters · filed 2014-02-06 | $1.15B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $300.09M 10-Q · filed 2013-04-25 | $584.00M derived: sum of 2 quarters · filed 2014-02-06 | $845.40M derived: sum of 3 quarters · filed 2014-02-06 | $1.11B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $283.92M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $545.31M derived: sum of 2 quarters · filed 2014-02-06 | $811.62M derived: sum of 3 quarters · filed 2014-02-06 | $1.06B 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $261.40M 10-Q · filed 2012-10-25 | $527.70M derived: sum of 2 quarters · filed 2012-10-25 | $772.22M 10-Q · filed 2012-10-25 | $1.05B derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | $266.30M 10-Q · filed 2012-07-24 | $510.82M 10-Q · filed 2012-07-24 | $787.21M derived: sum of 3 quarters · filed 2013-02-05 | $1.03B derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | $244.52M 10-Q · filed 2012-05-01 | $520.91M derived: sum of 2 quarters · filed 2013-02-05 | $765.07M derived: sum of 3 quarters · filed 2013-02-05 | $1.03B derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | $276.39M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $520.55M derived: sum of 2 quarters · filed 2013-02-05 | $782.88M derived: sum of 3 quarters · filed 2013-02-05 | $1.03B 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | $244.16M 10-Q · filed 2011-10-28 | $506.48M derived: sum of 2 quarters · filed 2011-10-28 | $755.15M 10-Q · filed 2011-10-28 | $996.76M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | $262.32M 10-Q · filed 2011-07-26 | $510.99M 10-Q · filed 2011-07-26 | $752.61M derived: sum of 3 quarters · filed 2012-02-03 | $979.36M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | $248.66M 10-Q · filed 2011-04-21 | $490.28M derived: sum of 2 quarters · filed 2012-02-03 | $717.04M derived: sum of 3 quarters · filed 2012-02-03 | $937.87M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | $241.62M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $468.37M derived: sum of 2 quarters · filed 2012-02-03 | $689.20M derived: sum of 3 quarters · filed 2012-02-03 | $911.03M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $226.75M 10-Q · filed 2010-10-26 | $447.58M derived: sum of 2 quarters · filed 2010-10-26 | $669.41M 10-Q · filed 2010-10-26 | $900.38M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-06-30 | $220.83M 10-Q · filed 2010-07-20 | $442.66M 10-Q · filed 2010-07-20 | $673.62M derived: sum of 3 quarters · filed 2011-02-04 | $906.45M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-03-31 | $221.83M 10-Q · filed 2010-04-20 | $452.79M derived: sum of 2 quarters · filed 2011-02-04 | $685.62M derived: sum of 3 quarters · filed 2011-02-04 | $931.31M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2008-12-31 | $230.96M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $463.79M derived: sum of 2 quarters · filed 2011-02-04 | $709.48M derived: sum of 3 quarters · filed 2011-02-04 | $925.30M 10-K · filed 2011-02-04 | ||||
| 2008-09-30 | $232.82M 10-Q · filed 2009-10-21 | $478.51M derived: sum of 2 quarters · filed 2009-10-21 | $694.34M 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | $245.69M 10-Q · filed 2009-07-17 | $461.52M 10-Q · filed 2009-07-17 | ||||||
| 2007-12-31 | $776.10M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |